NIH Record - National Institutes of Health

Study Shows Promising Therapy for Drug-Resistant Klebsiella Pneumoniae

A promising strategy to tame troublesome drug-resistant bacteria is bacteriophage, or phage therapy, which uses viruses instead of antibiotics. NIH scientists have used two different bacteriophage viruses individually and then together to successfully treat research mice infected with multidrug-resistant Klebsiella pneumoniae sequence type 258 (ST258).

Four Potential Therapeutics for Covid Enter Phase 2/3 Testing

Enrollment has begun to test additional investigational drugs in the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) program. ACTIV, sponsored by NIAID, is a public-private partnership that creates a coordinated research strategy to prioritize and speed development of promising Covid-19 treatments and vaccines.

Combination Treatment for Glioma Shows Promise

In an NIH-funded study, researchers tested a novel combination treatment on mice with tumors with characteristics similar to human astrocytomas—a type of slow-growing glioma—and found tumor regression in 60 percent of the mice treated.

Computerized Screener Helps Detect Youth Suicide Risk

Researchers have developed a computerized adaptive screener to identify youth at risk for attempting suicide. In a new study, the computerized adaptive screen for suicidal youth (CASSY) correctly identified 82.4 percent of youth who went on to attempt suicide in the 3 months after screening.

Meth Overdose Deaths Rise Sharply Nationwide

Methamphetamine overdose deaths surged in an 8-year period in the U.S., according to a new NIDA study published in JAMA Psychiatry. The analysis revealed rapid rises across all racial and ethnic groups, but American Indians and Alaska Natives had the highest death rates overall.

NIH Scientists Identify Nutrient that Helps Prevent Infection

Scientists studying the body’s natural defenses against bacterial infection have identified a nutrient—taurine—that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in Cell by investigators from five NIH institutes, could aid efforts seeking alternatives to antibiotics.

Full-Dose Blood Thinners Improve Outcomes in Hospitalized Covid Patients

In large clinical trials, full-dose anticoagulation (blood thinner) treatments given to moderately ill patients hospitalized for Covid-19 reduced the need for vital organ support, such as ventilation. A trend in reduced mortality was also observed and is under further study. With large numbers of Covid-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world.

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Editor: Dana Talesnik
Dana.Talesnik@nih.gov

Associate Editor: Patrick Smith
Pat.Smith@nih.gov

Assistant Editor: Eric Bock
Eric.Bock@nih.gov

Staff Writer: Amber Snyder
Amber.Snyder@nih.gov